Trials / Sponsors / Reid Merryman, MD
Reid Merryman, MD
Academic / Other · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Epco, Zanu, Ritux for R/R FL or MZL Follicular Lymphoma, Lymphoma, Non-Hodgkin Lymphoma | Phase 2 | 2025-01-21 |
| Active Not Recruiting | Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma | Phase 2 | 2023-07-18 |
| Recruiting | Epcoritamab and Rituximab for First-line Follicular Lymphoma Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult | Phase 2 | 2023-06-21 |